Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Jun 23, 2016	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-16-109550.pdf 0001144204-16-109550.rtf 0001144204-16-109550.xls
Jun 23, 2016	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-16-109554.pdf 0001144204-16-109554.rtf 0001144204-16-109554.xls
Jun 7, 2016	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0000320017-16-000130.pdf 0000320017-16-000130.rtf 0000320017-16-000130.xls
Jun 7, 2016	4/A	Amendment to a previously filed 4	View HTML 0001144204-16-107350.pdf 0001144204-16-107350.rtf 0001144204-16-107350.xls
Jun 6, 2016	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-16-107135.pdf 0001144204-16-107135.rtf 0001144204-16-107135.xls
Jun 6, 2016	EFFECT	EFFECT	View HTML 9999999995-16-004839.pdf 9999999995-16-004839.rtf 9999999995-16-004839.xls
Jun 3, 2016	CORRESP	CORRESP	View HTML 0000320017-16-000128.pdf 0000320017-16-000128.rtf
May 16, 2016	CT ORDER	CT ORDER	View HTML 9999999997-16-022937.pdf
May 10, 2016	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0000320017-16-000124.pdf 0000320017-16-000124.rtf 0000320017-16-000124.xls
May 10, 2016	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0000320017-16-000123.pdf 0000320017-16-000123.rtf 0000320017-16-000123.xls